LEISH2b - A phase 2b study to assess the safety, efficacy, and immunogenicity of the Leishmania vaccine ChAd63-KH in post-kala azar dermal leishmaniasis

por Lacey, Charles, Musa, Ahmed, Khalil, El Tahir, Younis, Brima, Osman, Mohamed, Wiggins, Rebecca, Keding, Ada, Kaye, Paul
Publicado 2022

The Economic Burden of Visceral Leishmaniasis in Sudan: An Assessment of Provider and Household Costs

por Meheus, Filip, Abuzaid, Abuzaid A., Baltussen, Rob, Younis, Brima M., Balasegaram, Manica, Khalil, Eltahir A. G., Boelaert, Marleen, Musa, Ahmed M.
Publicado 2013

Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients

por Salih, Mohamed A M, Fakiola, Michaela, Abdelraheem, Mohamed H, Younis, Brima M, Musa, Ahmed M, ElHassan, Ahmed M, Blackwell, Jenefer M, Ibrahim, Muntaser E, Mohamed, Hiba S
Publicado 2014

Paromomycin for the Treatment of Visceral Leishmaniasis in Sudan: A Randomized, Open-Label, Dose-Finding Study

por Musa, Ahmed M., Younis, Brima, Fadlalla, Ahmed, Royce, Catherine, Balasegaram, Manica, Wasunna, Monique, Hailu, Asrat, Edwards, Tansy, Omollo, Raymond, Mudawi, Mahmoud, Kokwaro, Gilbert, El-Hassan, Ahmed, Khalil, Eltahir
Publicado 2010

Visceral leishmaniasis-hepatitis B/C coinfections: a rising necessity to triage patients for treatment

por Adam, Abubakr O. A., Dafalla, Mohamed M. M., Mohammed, Hatim A. A., Elamin, Mohamed Y., Younis, Brima M., Elfaki, Mona E. E., Musa, Ahmed M., Elhassan, Ahmed M., Khalil, Eltahir A. G.
Publicado 2014

Safety and Efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Afri...

por Omollo, Raymond, Alexander, Neal, Edwards, Tansy, Khalil, Eltahir AG, Younis, Brima M, Abuzaid, Abuzaid A, Wasunna, Monique, Njoroge, Njenga, Kinoti, Dedan, Kirigi, George, Dorlo, Thomas PC, Ellis, Sally, Balasegaram, Manica, Musa, Ahmed M
Publicado 2011

Visceral leishmaniasis relapse hazard is linked to reduced miltefosine exposure in patients from Eastern Africa: a population pharmacokinetic/pharmacodynamic study

por Dorlo, Thomas P C, Kip, Anke E, Younis, Brima M, Ellis, Sally J, Alves, Fabiana, Beijnen, Jos. H, Njenga, Simon, Kirigi, George, Hailu, Asrat, Olobo, Joseph, Musa, Ahmed M, Balasegaram, Manica, Wasunna, Monique, Karlsson, Mats O, Khalil, Eltahir A G
Publicado 2017

Blood Parasite Load as an Early Marker to Predict Treatment Response in Visceral Leishmaniasis in Eastern Africa

por Verrest, Luka, Kip, Anke E, Musa, Ahmed M, Schoone, Gerard J, Schallig, Henk D F H, Mbui, Jane, Khalil, Eltahir A G, Younis, Brima M, Olobo, Joseph, Were, Lilian, Kimutai, Robert, Monnerat, Séverine, Cruz, Isra, Wasunna, Monique, Alves, Fabiana, Dorlo, Thomas P C
Publicado 2021

Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan

por Younis, Brima M., Osman, Mohamed, Khalil, Eltahir A.G., Santoro, Francesco, Furini, Simone, Wiggins, Rebecca, Keding, Ada, Carraro, Monica, Musa, Anas E.A., Abdarahaman, Mujahid A.A., Mandefield, Laura, Bland, Martin, Aebischer, Toni, Gabe, Rhian, Layton, Alison M., Lacey, Charles J.N., Kaye, Paul M., Musa, Ahmed M.
Publicado 2021

Safety and Efficacy of Single Dose versus Multiple Doses of AmBisome® for Treatment of Visceral Leishmaniasis in Eastern Africa: A Randomised Trial

por Khalil, Eltahir A. G., Weldegebreal, Teklu, Younis, Brima M., Omollo, Raymond, Musa, Ahmed M., Hailu, Workagegnehu, Abuzaid, Abuzaid A., Dorlo, Thomas P. C., Hurissa, Zewdu, Yifru, Sisay, Haleke, William, Smith, Peter G., Ellis, Sally, Balasegaram, Manica, EL-Hassan, Ahmed M., Schoone, Gerard J., Wasunna, Monique, Kimutai, Robert, Edwards, Tansy, Hailu, Asrat
Publicado 2014

Geographical Variability in Paromomycin Pharmacokinetics Does Not Explain Efficacy Differences between Eastern African and Indian Visceral Leishmaniasis Patients

por Verrest, Luka, Wasunna, Monique, Kokwaro, Gilbert, Aman, Rashid, Musa, Ahmed M., Khalil, Eltahir A. G., Mudawi, Mahmoud, Younis, Brima M., Hailu, Asrat, Hurissa, Zewdu, Hailu, Workagegnehu, Tesfaye, Samson, Makonnen, Eyasu, Mekonnen, Yalemtsehay, Huitema, Alwin D. R., Beijnen, Jos H., Kshirsagar, Smita A., Chakravarty, Jaya, Rai, Madhukar, Sundar, Shyam, Alves, Fabiana, Dorlo, Thomas P. C.
Publicado 2021

Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial

por Musa, Ahmed M, Mbui, Jane, Mohammed, Rezika, Olobo, Joseph, Ritmeijer, Koert, Alcoba, Gabriel, Muthoni Ouattara, Gina, Egondi, Thaddaeus, Nakanwagi, Prossy, Omollo, Truphosa, Wasunna, Monique, Verrest, Luka, Dorlo, Thomas P C, Musa Younis, Brima, Nour, Ali, Taha Ahmed Elmukashfi, Elmukashfi, Ismail Omer Haroun, Ahmed, Khalil, Eltahir A G, Njenga, Simon, Fikre, Helina, Mekonnen, Tigist, Mersha, Dagnew, Sisay, Kasaye, Sagaki, Patrick, Alvar, Jorge, Solomos, Alexandra, Alves, Fabiana
Publicado 2022